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ABSTRACT
Objectives: To investigate ability to distinguish simple analgesics, to document
misconceptions about aspirin use, and to identify strategies to diminish potentially
harmful aspirin use in Ethiopia.
Design: Qualitative study (eight focus group discussions) used to inform cross-sectional
survey.
Setting: Butajira, a small town in southern Ethiopia, and surrounding rural areas.
Participants: Purposively selected informants for focus groups; random sample of urban
and rural residents for cross-sectional survey.
Main outcome measures: Ability to distinguish aspirin from paracetamol; proportion
using aspirin; proportion aware of common risks of aspirin.
Results: Questionnaires were completed by 204 of the 250 residents sampled (82%
response). Three-quarters of survey participants knew the difference between aspirin
and paracetamol. Aspirin was used by 7.3% of respondents, and was mainly taken for
headache and fever. In focus group discussions there was a suggestion that aspirin was
considered particularly useful for children. There was very low awareness of the risks
of using aspirin in children (2.5% unprompted, 18.6% prompted) or in people with
asthma (1% unprompted, 5.9% prompted). Aspirin is cheap and widely available in
urban and rural areas.
Conclusion: Awareness of the risks of aspirin use by children and in asthma is extremely
low in this rural Ethiopian setting. Medications are purchased with minimal packaging
by a population with low literacy. Drug dispensers and vendors must be trained to convey
simple verbal warnings about aspirin use.
INTRODUCTION
In many African countries, medications are acquired
from a range of public and private providers, including
clinics, health stations, pharmacies, retailers in
established shops or transient market places, and
individual practitioners working from their homes (1,2).
In Dakar, the amount spent on medications sold by
unregistered vendors in underprivileged suburbs was
estimated at eleven-fold that of government
pharmaceutical expenditure in the same area (2). In
rural Ghana, most people bought medications without
a prescription, misinformation was found to be common,
and even when registered chemists were approached,
many propagated misuse of medication by selling
according to popular demand (3).
Research into over-the-counter (non-prescription)
acquisition of medications in developing countries has
chiefly focused on antibiotics (4,5) and antimalarials
(1,6,7). However, painkillers and antipyretics have been
shown to be widely stocked (1) and sold (2). Studies
addressing home case management of malaria (6) and
the appropriateness of drugs used to treat fever in
children (7) have suggested potentially dangerous use
of aspirin. Recently, a community-based survey
conducted among adults in Jos, Nigeria demonstrated
high prevalence of self-medication with analgesics,
with 22.6% of respondents falling into the category
defined as ‘abuse’ (cumulative lifetime use of more
than 5000 pills) (8). This community-based work is
complemented by a hospital-based report of aspirin
overdose in Kenyan children with malaria (9).
Patterns of availability and use of aspirin and
paracetamol have not been explored in Ethiopia. In
2003, in the course of a study of the association
between wheeze, allergic sensitisation and geohelminth
infection (10), we demonstrated an association between
paracetamol use and allergic symptoms (11). In order
to explore this association further and rule out alternative
explanations for it, we designed qualitative and
quantitative studies on perceptions and use of
paracetamol and aspirin in the same community.
This article describes use of aspirin, knowledge of
contra-indications to its use, and issues surrounding
accessibility and availability among people able to
distinguish aspirin from paracetamol. Quantitative survey
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data are used to complement information from focus
group discussions. Strategies through which misuse
may be minimised in future are then proposed.
MATERIALS AND METHODS
Study site: The studies took place in and around
Butajira, a small town located 135 km south of Addis Ababa,
the capital of Ethiopia. Butajira was chosen for the present
study as it is the site of the Butajira Rural Health Project,
a demographic surveillance project covering more than
40,000 residents of the town and surrounding rural areas.
Approximately 15% of people included in the surveillance
project live in Butajira town which has a hospital, health
centre, secondary school, post office and hydroelectricity
supply, and is connected to Addis Ababa by an all-weather
road. The other participants live in villages served by unmade
roads, and are predominantly agriculturalists growing coffee,
pepper, the stimulant chat and the cereal t ff (l2).
Sampling frame and sample selection.
Qualitative study: Non-probabilistic sampling was
performed to form eight focus groups representing urban men,
urban women, rural men, rural women, health care providers
(dispensers grouped separately from prescribers), men with
allergic symptoms and women with allergic symptoms,
respectively. We aimed to recruit between six and eight
participants to each focus group. ‘Urban’ participants were
those residing in the single Urban Development Association
(UDA) included in the Butajira Rural Health Project (BRHP).
‘Rural’ participants were recruited from those residing in Bati,
a rural area approximately 10 km from Butajira town. Health
care providers were recruited from Butajira Hospital and
Butajira Clinic, and included prescribers and dispensers from
these health facilities, dispensers from private pharmacies in
Butajira town, and rural drug vendors. People with allergic
symptoms were recruited from those identified on our
database as having reported wheeze, asthma, rhinitis, eczema
or a combination of these symptoms and conditions in the
cross-sectional survey performed one year previously.
Quantitative study: The sampling frame comprised
individuals aged 5 years and over in 2003 who had participated
in the earlier cross-sectional survey and resided in the urban
area or one of four rural areas selected from the total of nine
rural areas for ease of access during the rainy season. We
randomly selected a sample of 250 people from the general
population responding to the 2003 survey for the present
study; we also studied selected groups of people who reported
wheeze or asthma, rhinitis or eczema (data reported in
reference 11). All results presented in this paper are from
the general population sample.
Conduct of focus group discussions, and qualitative data
analysis: Discussions were guided by two experienced
facilitators, one female (who facilitated the women’s groups),
and one male (who facilitated the men’s groups and the
prescribers and dispensers groups). They used a check list
to ensure coverage of certain key areas, including beliefs
about the uses and adverse effects of paracetamol, aspirin and
other non-steroidal anti- inflammatory drugs, conditions for
which each may be used, circumstances when each should
not be used, accessibility and price. Refreshments were
provided to participants and transport was arranged for health
workers from the hospital, but no other reimbursement was
made. Focus group discussions were tape recorded, and brief
hand-written notes were taken simultaneously. The tape
recordings were transcribed and translated into English by
the facilitators. Transcripts were read repeatedly and manually
coded by the facilitators, PD, GA- A and GD together. Data
relating to aspirin are presented thematically, using quotes
translated into English where appropriate.
Study instrument, survey methods and quantitative data
analysis: A questionnaire was developed using the results
of the qualitative study. With it, we checked whether people
had heard of paracetamol and aspirin and knew that they
were different, the frequency and quantity of paracetamol
and aspirin use, indications for use of both medications,
knowledge of adverse effects and contraindications to use,
availability, cost and preference for one medication over the
other. The questionnaire was prepared in English, translated
into Amharic and back-translated to ensure accuracy. Seven
local data collectors who had experience in previous field
surveys were trained for three days in explaining the study,
taking consent and administering the questionnaire. They
were trained to administer the questionnaire to parents or
adult caretakers of children aged 12 years and younger, and
supervised during a pilot among adults and children who
did not form part of the study sample. Supervisors checked
questionnaires and returned to do random checks and checks
wherever inconsistencies appeared. Data were double entered
into EPI-Info version 6.1 in Butajira, the duplicate entries
compared and cleaned in Addis Ababa, and the cleaned
dataset exported to SPSS version 10 for all further analysis.
A new variable indicating knowledge of the difference
between paracetamol and aspirin was created on the basis
of stating that paracetamol was not the same as aspirin or
correctly identifying paracetamol from aspirin on being
handed strips of each medication. Variables indicating ‘ever’
consumption of paracetamol and aspirin, and monthly
consumption of each medication were created. Other outcome
variables were created in response to the questions ‘Can you
name symptoms for which you have taken paracetamol (or
aspirin)?’; Should any people NOT take paracetamol (or
aspirin)?’; ‘Is paracetamol (or aspirin) available close to
where you live?’; ‘Is paracetamol (or aspirin) affordable to
you?’; ‘Do you prefer to use paracetamol or aspirin?’ and
‘What affects your preference most?’. Demographic data on
s x, age, urban or rural residence and highest educational
level attained (by father if the respondent was aged less than
12 years) were transferred from the 2003 dataset by
matching with individual identification number, and
educational level was categorised dichotomously according
to ability to read and write. Univariate associations between
outcome variables and demographic variables were assessed
using the chi-squared test, and binary logistic regression was
used to identify the independent determinants of each
outcome. Data relating to use of aspirin are presented here.
Ethical Considerations: Ethical approval was granted by
the Research and Publications Committee of the Department
of Community Health, Addis Ababa University. On completion
of field work for the study, three simple statements about
the safe use of aspirin and paracetamol were developed,
translated into Amharic and distributed to prescribers,
dispensers and community leaders in the Butajira area.
January 2006 EAST AFRICAN MEDICAL JOURNAL 33
RESULTS
Focus group discussions: Group size ranged from
four participants (dispensers) to eleven participants
(allergic men), and the time spent in discussion ranged
from 40 minutes (prescribers) to 95 minutes (allergic
women). Age of participants ranged from 17 to 68
years.
Questionnaire survey: response rate and socio-
demographic characteristics. The response rate for the
questionnaire survey was 204/250 (82%), of whom
42.6% were male, and the median age was 19 years
(range 6 to 81 years). 63.7% were urban residents,
36.8% could neither read nor write and 12.7% had
reported asthma or wheeze in 2003 (Table 1).
Respondents who had never heard of paracetamol or
aspirin, or did not know the difference between them,
were not asked detailed questions about consumption,
indications and adverse effects. Therefore 153 individuals
responded to detailed questions on paracetamol, and
124 to detailed questions on aspirin.
Table 1
Demographic and health characteristics of respondents in
quantitative survey (n = 204)
All subjects No. (%)
Gender Male 87 42.6
Female 117 57.4
Area of residence Urban 130 63.7
Rural 74 36.3








Level of literacy* Unable to read 75 36.8
or write
Able to read 129 63.2
or write
Self-reported asthma Yes 26 12.7
or wheeze in 2003 No 178 87.3
* of respondent, or father if respondent was aged 12 years
or below
Identification, naming and ability to distinguish
between paracetamol and aspirin: Not all of the focus
group discussion (FGD) participants had heard of
aspirin. Urban residents seemed to be more familiar
with aspirin than rural residents and it appeared to be
most well known amongst the urban men, who had all
heard of it, and least well known amongst the rural
women. When prompted with strips of aspirin tablets,
two of the rural women responded, ‘we don’t know by
its name’ and ‘we don’t identify it by its name’
respectively. Aspirin was identified and described as
a drug for pain, fever, headache and rheumatic pain.
One urban male identified aspirin as a ‘recommended
anti-pain for children’. From the dispensers and
prescribers, it seemed that aspirin was identified by the
general population either by name (including the brand
names Asprone and Vinac for aspirin) or by its effect
(for example ‘antipain’ or ‘antipyretic’).
In the questionnaire survey, 156 (76.5%) knew
paracetamol and aspirin were different medications. In
accord with the FGD findings, the ability to distinguish
was higher among men than women (85.1% vs 70.1%,
p = 0.01), in the urban area than the rural areas (81.5%
vs 67.6%, p = 0.02), in younger age groups than older
(Ptrend = 0.027) and in those who could read and write
than those who could not (84.5% vs 62.7%, P<0.001).
After adjustment for literacy, age and area of residence,
sex remained borderline significantly associated with
ability to distinguish analgesics (OR before adjustment
2.43, 95% CI = 1.19 to 4.94; after adjustment
2.17, 95% CI = 1.01 to 4.68).
Indications for use of aspirin: Across all of the
FGDs, aspirin was reported to be used for headache
and fever. Other indications mentioned in some groups
included rheumatic pain, toothache, fever and headache
due to malaria, chest pain and ‘birrd’ (symptoms of
internal cold and chills). Several of the health
professionals emphasised the additional anti-
inflammatory effects of aspirin. A dispenser said that
aspirin was ‘the same as paracetamol but in addition
to this effect aspirin has an anti-inflammatory effect
which is used for rheumatic pain’.
The indications mentioned in the FGDs were
confirmed among those using aspirin in the survey.
7.3% of respondents had ever used aspirin, and only
4.8% of aspirin users had taken one tablet or more per
month. The indications spontaneously mentioned most
often were headache (all of 9 users), fever (4 of 9),
and birrd (2 of 9). There were no differences by sex,
area of residence or literacy for those using aspirin for
fever and birrd.
Adverse effects and contraindications: The
discussions varied depending on whether the group
contained health practitioners or lay people. Most
residents were unaware of the conditions under which
aspirin should not be taken. Only one urban man,
having himself suffered following use from ‘gastric
irritation’ was aware that those with gastric problems
should not consume aspirin.
Prescribers and dispensers stated that conditions
such as gastritis, bleeding disorders and peptic ulcers
would prevent them giving aspirin. Two important
contraindications were highlighted by a single individual
in each of these groups. One dispenser said he would
not give aspirin to an asthmatic, since ‘it is an allergen
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by itself ’. One prescriber emphasised the problem of
aspirin use in ‘viral syndrome in children’. Though he
did not know the name, he did mention that it was fatal.
In the questionnaire survey, 69 of 120 respondents
(57.5%) considered that there were no problems related
to taking aspirin. Of the 22 who thought there were
problems with taking aspirin, 19 mentioned gastric
irritation and six masking malaria as problems. When
asked the open question ‘should aspirin be avoided by
any groups’, only five (2.5%) respondents said children;
a further 38 answered yes when asked specifically if it
should be avoided by children. There were no significant
differences in knowing children should avoid aspirin by
sex, age, literacy or area of residence. Two respondents
(one an asthmatic) thought aspirin should be avoided in
asthma and a further 12 when prompted.
Availability and Cost: FGD respondents considered
aspirin to be widely available in urban and rural areas.
Sources universally mentioned were pharmacies, health
institutions (hospitals, health centres), private clinics
and shops. Shops were the most common source in the
urban area, because of long opening hours ‘they are
open till 10-11pm while pharmacy not so’. Despite
affirming the extensive availability of aspirin, there
were still individuals who claimed they preferred
paracetamol since it was more ‘easily ‘ or ‘commonly’
available than aspirin.
The cost of aspirin was said to vary slightly by
place of purchase. It was cheaper to buy at health
institutions and pharmacies, costing approximately 1
birr (£0.07) for a strip of ten tablets.
Qualitative information was backed up by the
questionnaire survey, with 76.7% of respondents stating
that aspirin was available close to their homes. Rural
residents were less likely than urban residents to find
aspirin close to their homes (48.6% vs 88.0%, p<0.001).
Females were more likely to report aspirin to be
available (87.7% vs 72.4%, p=0.033) than males.
Address remained an independent predictor of reported
availability of aspirin after adjustment for age, sex and
literacy (OR for rural vs urban availability 0.073, 95%
CI 0.019 to 0.275).
Aspirin was said to be affordable by 86.8% of
respondents. There was no significant urban-rural
difference in stated aspirin affordability. There were no
significant differences in affordability of aspirin by sex
or literacy, and the effect of address diminished and
became non-significant when controlled for age, sex
and literacy.
Preferences: Most residents chose paracetamol
over aspirin as their preferred drug. Although the
reasons varied within the groups the dominating factors
were recommendations by health care professionals and
the wider perceived availability of paracetamol. A few
respondents preferred aspirin. There were two main
reasons for preference of aspirin over paracetamol.
Firstly, health care professionals acknowledged the use
of aspirin for its anti-inflammatory properties: ‘depending
on desired effect if anti-inflammation is needed aspirin
is my preferred drug’. Secondly, respondents mentioned
preferring aspirin for children, as it was available
locally in a child formulation known as ‘baby aspirin’.
Only one respondent, a prescriber showed any awareness
of the potential dangers of administering aspirin to
children (see above under Adverse Effects).
DISCUSSION
We found that despite some confusion over the
name of aspirin in the rural area, the majority of the
general population knew that paracetamol was different
from aspirin. This knowledge was strongly associated
with literacy, partly because the strips of tablets that
respondents were handed had the type of tablet written
(in Amharic) on the back. Literate respondents can
normally identify medications in this manner if tablets
are dispensed in strips rather than individually. However,
medications may be dispensed in paper envelopes,
hindering identification by the user.
In this study, aspirin was used by relatively few
respondents (7.3%), and only 4.8% took one or more
tablets per month. In a metropolitan setting in Nigeria
where analgesic mixtures, piroxicam and ibuprofen
were available and more commonly used than aspirin,
only 3% had ever used aspirin (8). However, the
evidence we gathered suggests that aspirin use is less
than in Dakar, Senegal, where aspirin sales were
estimated at 58% of illicit pharmaceutical sales (2).
Although we did not elicit information from which to
calculate lifetime consumption, the monthly consumption
estimates suggest it is unlikely that analgesic abuse is
occurring on the scale reported in Nigeria (8). In this
study, 22.6% of respondents had lifetime use of more
than 5000 pills, a quantity associated with increased
risk of end stage renal disease (13).
Aspirin was used predominantly for headache
(100%), fever (44%), and birrd (22%). Indications for
use were documented in Jos, Nigeria (8). In this
metropolitan population, the most common indications
for analgesic use were rheumatological (89%), headache
(67%), fever (8%) and stress (7%). The authors comment:
‘Advertising for these [analgesic] products is
aggressive...It is the norm to see billboards and other
media advertising them’. Advertising may influence
indications for use, but is as yet uncommon in any
media form in rural Ethiopia. This difference in
advertising, and possibly a difference in prevalence of
malaria fever, may explain the different patterns of
indications for use in the two communities.
Although aspirin was not used as often as
paracetamol, several focus group participants
considered aspirin to be the analgesic of choice for
children, and referred to a ‘baby aspirin’ formulation.
Very few questionnaire respondents considered that
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children should not take aspirin. Only one health care
professional knew there was potential danger using
aspirin in children but even he could not be explicit.
The risk of Reye’s syndrome is low at approximately
1:1,000,000, but febrile children with Reye’s syndrome
are 35 times more likely to have been given aspirin
than those without. Since 1986, aspirin manufacturers
have been required to add warnings about Reye’s
syndrome to product labels in most developed countries,
but these warnings do not appear to have penetrated
through to dispensers and consumers in this rural
setting. There are reports of use of aspirin for fever
in children in other African countries. Use of ‘baby’
or ‘Junior’ aspirin formulation has been reported in
Kenya (6), and concerns regarding aspirin overdose
in febrile Kenyan children have been raised (9).
Aspirin was used in 36.7% of feverish children prior
to enrolment into a study of malaria treatment in
Uganda (7). These investigators found that aspirin was
recommended more frequently than paracetamol by
private drug shop attendants, whereas paracetamol
was more frequently prescribed in government health
facilities (7).
Very few questionnaire respondents considered that
aspirin should not be used in asthma. Only one dispenser
stated that he would not dispense aspirin in asthma. The
prevalence of diagnosed asthma has been estimated at
between 2% and 3% in studies in rural and urban Ethiopia
(14,15), while the prevalence of self-reported wheeze is
10% to 18%. Systematic review of studies in which aspirin
sensitivity in people with asthma was reported suggests
prevalence of aspirin induced asthma of 21% (95% CI
14% to 29%) (16). Given a population of approximately
70 million, 294,000 (70 x 106 x 2% x 21%) Ethiopians
may experience aspirin induced asthma.
We identified three major issues in conveying the
health risks of common medications to users. Firstly,
a large proportion of the population is unable to read
their first language (in our study area, Guraginya or
Amharic, but more than seventy languages are used
in Ethiopia), and an even greater proportion would be
unable to read packaging or information leaflets in
English. Secondly, analgesics are usually sold in twos
or in strips of ten tablets, so information given on or
inside the container is not given to users with the
tablets. Thirdly, many prescribers and dispensers were
unaware of basic contra-indications to use of aspirin,
though unlike investigators in rural Ghana (3), we
found no evidence of deliberate provision of
misinformation. Prescribers, dispensers and vendors
must therefore be trained to make basic contra-
indication checks and to give accurate verbal
information even when this conflicts with their ability
to make a sale.
Strategies to minimise misuse: The results of this
study suggest that strategies should be designed at
different levels to minimise misuse of aspirin. First, at
policy level, manufacturers must be required to transfer
observation of guidelines that exist in more-developed
countries to countries like Ethiopia. This includes
withdrawal of formulations marketed as ‘baby’ or
‘junior’ aspirin. Another strategy, aimed at district-level
professionals, would be to provide accurate information
on contra-indications to dispensers and prescribers of
analgesics. This group is literate, and so simple written
information about groups of people who should avoid
aspirin might be used. This might be provided in the
packaging of analgesics, or independently in poster
format. At community level, dissemination of
information on risks associated with use of aspirin by
children or people with asthma to the general population
would require longer term efforts, but might be achieved
through local opinion leaders.
In conclusion, in this rural Ethiopian population,
there are potentially dangerous misconceptions about
aspirin use, particularly among children and people
with asthma. Aspirin is cheap and available through a
number of outlets in urban and rural areas. It is often
dispensed with minimal packaging, limiting the
dissemination of warning messages through package
labels or inserts. The population is therefore highly
dependent on verbal advice from prescribers and
dispensers, among whom we also found low awareness
of adverse effects.
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